References
Schmid C et al (2007) Donor lymphocyte infusion in the treatment of first haematological relapse in allogeneic stem-cell transplantation in adults with acute myeloid leukaemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party. J Clin Oncol 25(31):4938–4945 Nov
Bug G et al (2005) High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation. Ann Hematol 84(11):748–754 Oct
de Lima M et al (2000) High-dose melphalan and allogeneic peripheral blood stem cell transplantation for treatment of early relapse after allogeneic transplant. Bone Marrow Transplant 26(3):333–338 Aug
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tempescul, A., Ianotto, JC., Eveillard, JR. et al. High-dose melphalan followed by a second bone marrow transplantation in early relapse of acute myeloid leukemia after bone marrow transplantation in children. Ann Hematol 87, 503–504 (2008). https://doi.org/10.1007/s00277-007-0432-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-007-0432-1